Biggest News Aggregation in the World
📰 Recursion Pharmaceuticals News

Recursion Pharmaceuticals News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.

CNBC Mad July 3, 2024

We just nailed down an eighth straight up day for the dow. Even the nasdaq, okay, it dipped 0. 3 and this is confounding to a lot of people who dont understand that what certain public figures say is not necessarily what they mean. It is s though the whole thing is choreographed like a netflix series, probably rated number eight on the new movies page, and although as exciting market strength is for me, actually, the latter is not so good. So, maybe you better watch it. Let me direct you to the ...
Game Plan Straight Days Home Depot Tell Us American People Combustion Engine

Christopher Gibson Sells 50,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]
Christopher Gibson Recursion Pharmaceuticals Needham Company Profund Advisors Recursion Pharmaceuticals Inc Institutional Trading Of Recursion Pharmaceuticals
Source: wkrb13.com

Christopher Gibson Sells 50,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of Recursion Pharmaceuticals stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total value of $421,000.00. Following the completion of the transaction, the chief executive officer now directly owns 758,738 […]
Christopher Gibson Securities Exchange Commission Advisor Group Recursion Pharmaceuticals Inc Needham Company Recursion Pharmaceuticals

Lingotto Investment Management LLP Purchases 1,100,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Lingotto Investment Management LLP lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 141.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,875,077 shares of the company’s stock after buying an additional 1,100,000 shares during the period. Recursion […]
Christopher Gibson Blake Borgeson Nomura Asset Management Co Quarter For Recursion Pharmaceuticals Quest Partners Gladstone Institutional Advisory

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Elevatus Welath Management Invests $243,000 in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Elevatus Welath Management acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,650 shares of the company’s stock, valued at approximately $243,000. Other institutional investors also recently bought and sold shares of the […]
Tina Marriott Blake Borgeson Quarter For Recursion Pharmaceuticals Needham Company Investment Management Vanguard Group Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science